Night blindness
MONDO:0004588Inability to see clearly in dim light.
Also known as: nyctalopia
42 clinical trials for this condition and its sub-types, 5 tagged with Night blindness itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Night blindness
-
Congenital stationary night blindness 2 trials · 5 incl. sub-types
14 sub-types
- Congenital stationary night blindness autosomal dominant 1 3 trials
- Congenital stationary night blindness autosomal dominant 2 1 trial
- Oguchi disease 0 trials Sub-types →
- X-linked congenital stationary night blindness 0 trials Sub-types →
- Cone-rod synaptic disorder, congenital nonprogressive 0 trials
- Congenital stationary night blindness 1B 0 trials
- Congenital stationary night blindness 1C 0 trials
- Congenital stationary night blindness 1D 0 trials
- Congenital stationary night blindness 1E 0 trials
- Congenital stationary night blindness 1F 0 trials
- Congenital stationary night blindness 1G 0 trials
- Congenital stationary night blindness 1H 0 trials
- Congenital stationary night blindness autosomal dominant 3 0 trials
- Night blindness, congenital stationary, type1i 0 trials
-
Abnormal threshold of rods 0 trials
-
Acquired night blindness 0 trials
Most studied deeper sub-types
-
New eye drops promise sharper night vision for Post-LASIK patients
Symptom relief CompletedThis study tested an eye drop (POS) in 200 adults who had poor night vision after LASIK or similar eye surgery. The goal was to see if the drops could help them see better in dim light, reducing problems like glare and halos. Participants used the drops for 15 days and had their …
Phase 3 • Sponsor: Ocuphire Pharma, Inc. • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Eye drops could brighten your night vision
Symptom relief CompletedThis study tested whether Nyxol eye drops can help people who have trouble seeing in dim light, often after eye surgeries like LASIK or cataract surgery. 144 adults received either the eye drops or a placebo for 8 days. The main goal was to see if Nyxol could improve vision in lo…
Phase 3 • Sponsor: Ocuphire Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC